Latest News
Search News
Understanding familial leukaemia
8th August 2019
In 2014, the charity Bloodwise awarded a 5-year programme grant to a team from Queen Mary University of London to support research to better understand the nature of the faulty genes responsible for an inherited/familial predisposition to MDS/AML.
Read more
Antibody therapy in pancreatic cancer
31st July 2019
Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion. Called avb6, the protein is present on the surface of more than 80 per cent of pancreatic ductal adenocarcinoma – the most common form of pancreatic cancer – and is vital to increase the successful growth and spread of the tumour cells.
Read more
London Cancer PhD Student Network
25th July 2019
The newly established London Cancer PhD Student network recently held its first event, which attracted over 60 PhD students from across London to the Barts Cancer Institute. Speakers from six institutes gave short chalk talks to describe their research.
Read more
New research funded by PCRF
19th July 2019
The Pancreatic Cancer Research Fund is supporting two new research projects at the Barts Cancer Institute, Queen Mary University of London. The projects, led by Professor Hemant Kocher and Dr Gunnel Halldén, will aim to identify ways to enhance the efficacy of treatments for pancreatic cancer, to ultimately help those affected by this devastating disease.
Read more
World Economic Forum, China
8th July 2019
Professor Fran Balkwill was selected as a high-level delegation to the World Economic Forum in Dalian, China, to discuss her work in cancer research. As one of three researchers selected by the European Research Council to attend, she participated in presentations, panel discussions and press conferences on the topic of ‘Tackling cancer from within – new perspectives’.
Read more
CRUK Career Establishment Award
4th July 2019
Dr Oliver Pearce has received a Cancer Research UK Career Establishment Award, which will fund a project that will look at restoring response to immunotherapy in triple-negative breast cancer.
Read more